SCHEMBL30926529

SCHEMBL30926529

Cc1ccc(NS(=O)(=O)c2cc(C(=O)Nc3cccc([N+](=O)[O-])c3)ccc2C)cc1C

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 11/20 0.85
▸ MEN1 O00255 10/20 0.85
▸ KMT2A Q03164 10/20 0.85
▸ LMNA P02545 4/20 0.85
▸ ALDH1A1 P00352 4/20 0.83
▸ POLB P06746 2/20 0.83
▸ SMN1; SMN2 Q16637 6/20 0.82
▸ MAPK1 P28482 2/20 0.77
▸ HTT P42858 1/20 0.77
▸ IDH1 O75874 1/20 0.64
▸ KDM4E B2RXH2 1/20 0.62
▸ TDP1 Q9NUW8 1/20 0.62
▸ L3MBTL1 Q9Y468 1/20 0.60
▸ CASP3 P42574 1/20 0.58
▸ SENP8 Q96LD8 1/20 0.58
▸ SENP7 Q9BQF6 1/20 0.58
▸ SENP6 Q9GZR1 1/20 0.58
▸ TP53 P04637 1/20 0.57
▸ BLM P54132 1/20 0.57
▸ NPC1 O15118 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27180025 1.00 MAPT (0.85) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27180922 0.92 MAPT (1.00) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27180386 0.92 MAPT (0.92) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL30926709 0.91 MEN1 (0.87) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27180448 0.91 ALDH1A1 (1.00) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27179683 0.91 MEN1 (0.87) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL30926946 0.90 MEN1 (0.79) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL27181608 0.90 MEN1 (0.79) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL30926692 0.90 MAPT (0.85) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL30926792 0.90 MAPT (0.85) MAPTMEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MAPT 4236/4885MEN1 4795/4885KMT2A 2544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback